{"id":7816,"date":"2021-01-23T18:33:12","date_gmt":"2021-01-23T18:33:12","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=7816"},"modified":"2021-01-23T18:36:46","modified_gmt":"2021-01-23T18:36:46","slug":"doktorlar-ingilterede-koronavirus-asi-dozlarinin-uygulama-araliginin-daha-kisa-olmasini-istiyor","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/doktorlar-ingilterede-koronavirus-asi-dozlarinin-uygulama-araliginin-daha-kisa-olmasini-istiyor\/","title":{"rendered":"Doktorlar; \u0130ngiltere’de koronavir\u00fcs a\u015f\u0131 dozlar\u0131n\u0131n uygulama aral\u0131\u011f\u0131n\u0131n daha k\u0131sa olmas\u0131n\u0131 istiyor"},"content":{"rendered":"

British Medical Council, 12 haftal\u0131k beklemenin a\u015f\u0131n\u0131n etkinli\u011fini azaltabilece\u011fi konusunda uyard\u0131.<\/p>\n

K\u0131demli doktorlar, a\u015f\u0131n\u0131n etkili olmas\u0131n\u0131 sa\u011flamak i\u00e7in Pfizer \/ BioNTech koronavir\u00fcs a\u015f\u0131s\u0131n\u0131n birinci ve ikinci dozu aras\u0131ndaki bo\u015flu\u011fun azalt\u0131lmas\u0131 gerekti\u011fi konusunda uyard\u0131.<\/p>\n

\"\"


( Emre Aytekin – Anadolu Ajans\u0131 )<\/p><\/div>\n

\u015eu anda hastalar ikinci dozlar\u0131n\u0131 almak i\u00e7in yakla\u015f\u0131k \u00fc\u00e7 ay beklemektedir. \u0130ngiltere’nin ba\u015f t\u0131p g\u00f6revlisi Prof.Chris Whitty, bunun \u00fclke \u00e7ap\u0131nda daha fazla insana ilk a\u015f\u0131y\u0131 yapt\u0131rmak i\u00e7in bir “halk sa\u011fl\u0131\u011f\u0131 karar\u0131” oldu\u011funu s\u00f6yledi.<\/p>

\"\"<\/a><\/div>\n

Guardia’\u0131n haberine g\u00f6re bununla birlikte, \u0130ngiliz Tabipler Birli\u011fi (BMA) Konseyi ba\u015fkan\u0131 Dr Chaand Nagpaul, bo\u015flu\u011fun a\u015f\u0131n\u0131n etkinli\u011fini azaltabilece\u011fini s\u00f6yledi. \u0130kinci dozu erteleme karar\u0131n\u0131n arkas\u0131ndaki mant\u0131\u011f\u0131 anlarken, \u0130ngiltere’nin “en iyi uygulamay\u0131” izlemesi ve bekleme s\u00fcresini alt\u0131 haftaya indirmesi gerekti\u011fini s\u00f6yledi.<\/p>\n

Oxford \/ AstraZeneca a\u015f\u0131s\u0131n\u0131n denemelerinden, 12 haftaya kadar ge\u00e7 bir ikinci dozun a\u015f\u0131n\u0131n etkinli\u011fini etkilemedi\u011fine dair baz\u0131 kan\u0131tlar olsa da, Pfizer, denemelerinden hi\u00e7bir kan\u0131t olmad\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n

Nagpaul, D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc’n\u00fcn analizine, Pfizer a\u015f\u0131s\u0131n\u0131n ikinci dozlar\u0131n\u0131n yaln\u0131zca “istisnai durumlarda” ertelenmesi gerekti\u011fini ve dozlar aras\u0131nda d\u00f6rt haftal\u0131k bir bo\u015fluk b\u0131rak\u0131lmas\u0131 gerekti\u011fini s\u00f6yledi.<\/p>\n

\u201cD\u00fcnyadaki \u00e7o\u011fu \u00fclke, s\u0131n\u0131rl\u0131 a\u015f\u0131 tedarikine sahip olmak ve ayn\u0131 zamanda n\u00fcfuslar\u0131n\u0131 azami \u00f6l\u00e7\u00fcde korumak istemekle \u0130ngiltere’ye benzer zorluklarla kar\u015f\u0131 kar\u015f\u0131ya. Nagpaul Cumartesi g\u00fcn\u00fc BBC Breakfast’a verdi\u011fi deme\u00e7te, \u0130ngiltere’nin yakla\u015f\u0131m\u0131n\u0131 ba\u015fka hi\u00e7bir \u00fclke benimsemedi \u201ddedi.<\/p>\n

“A\u00e7\u0131k\u00e7as\u0131 koruma alt\u0131 hafta sonra ortadan kalkmayacak, ancak bilmedi\u011fimiz \u015fey hangi koruma seviyesinin sunulaca\u011f\u0131 … sahip olmad\u0131\u011f\u0131m\u0131z verileri tahmin etmemeliyiz. De\u011fi\u015f toku\u015fu ve mant\u0131\u011f\u0131 anl\u0131yorum ama yap\u0131lacak do\u011fru \u015fey bu olsayd\u0131, di\u011fer uluslar\u0131n da buna uydu\u011funu g\u00f6r\u00fcrd\u00fck.<\/p>\n

“Sahip oldu\u011fumuz endi\u015fe … a\u015f\u0131n\u0131n etkinli\u011fi azal\u0131rsa … o zaman risk elbette vir\u00fcse maksimum d\u00fczeyde maruz kalanlar\u0131n enfekte olabilece\u011fini g\u00f6rece\u011fimizdir” diye ekledi. “Bir di\u011fer endi\u015fe de, en y\u00fcksek risk alt\u0131nda olan n\u00fcfusun \u00fcyelerinin korunamayaca\u011f\u0131d\u0131r.”<\/p>\n

H\u00fck\u00fcmetin A\u015f\u0131lama ve Ba\u011f\u0131\u015f\u0131klama Ortak Komitesi’ne g\u00f6re, yay\u0131nlanmam\u0131\u015f veriler Oxford \/ AstraZeneca a\u015f\u0131s\u0131n\u0131n dozlar 12 hafta arayla uyguland\u0131\u011f\u0131nda hala etkili oldu\u011funu g\u00f6steriyor. Ancak Pfizer, a\u015f\u0131n\u0131n etkinli\u011fini yaln\u0131zca iki doz 21 g\u00fcn arayla verildi\u011finde test etti\u011fini s\u00f6yledi.<\/p>\n

BMA, dozlar aras\u0131ndaki bo\u015fluktan duydu\u011fu endi\u015feyi belirtmek i\u00e7in Whitty’ye \u00f6zel olarak yazd\u0131. BBC taraf\u0131ndan g\u00f6r\u00fclen mektupta, politikan\u0131n “gerek\u00e7elendirilmesinin zor” oldu\u011fu belirtildi.<\/p>\n

Mektupta ayr\u0131ca Pfizer a\u015f\u0131s\u0131n\u0131n bir dozunun “yeterli n\u00f6tralize edici antikor \u00fcretmedi\u011fi ve bula\u015fmay\u0131 azaltma potansiyelinin az oldu\u011fu” endi\u015fesi de dile getirildi.<\/p>\n

\u0130ngiltere Halk Sa\u011fl\u0131\u011f\u0131 t\u0131bbi direkt\u00f6r\u00fc Prof Yvonne Doyle, a\u015f\u0131n\u0131n ertelenmesi karar\u0131n\u0131 savundu ve bunun “halk sa\u011fl\u0131\u011f\u0131 ve bilimsel tavsiyelere” dayand\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n

\u201cBu vir\u00fcse kar\u015f\u0131 ne kadar \u00e7ok insan korunursa, \u00fcst\u00fcnl\u00fck sa\u011flamak i\u00e7in o kadar  f\u0131rsat olacakt\u0131r. BBC Radio 4\u2019\u00fcn Today program\u0131na verdi\u011fi deme\u00e7te, daha fazla insan\u0131 korumak yap\u0131lacak do\u011fru \u015feydir.<\/p>\n

\u201c\u0130nsanlar ikinci dozlar\u0131n\u0131 alacaklar. Malzemeler mevcut olduk\u00e7a daha fazla insan a\u015f\u0131lanacakt\u0131r. Hem tedarik hem de \u00e7o\u011fu insan\u0131 korumaya dayal\u0131 makul bir bilimsel denge. ”<\/p>\n

\n

We have vaccinated over 5.8 million people in the UK, with a record 478,000 first doses given in a single day yesterday.<\/p>\n

Every jab brings us closer to defeating the virus. If you\u2019re called for the vaccine, please do come forward. pic.twitter.com\/BWO1cYcsfQ<\/a><\/p>\n

\u2014 Boris Johnson (@BorisJohnson) January 23, 2021<\/a><\/p><\/blockquote>\n